BioSpace News Archive

BioMidwest

Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.

February 22, 2022

·

1 min read

Business

InspireMD to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022 and Provide Corporate Business Update

InspireMD, Inc. announces it will report fourth quarter and full year 2021 financial results on Tuesday, March 8, 2022, before the market opens.

February 22, 2022

·

3 min read

Pharm Country

Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common Stock

Ocugen, Inc. announced the pricing of its underwritten public offering of approximately 15,973,420 million shares of its common stock for gross proceeds of approximately $53.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Ocugen.

February 22, 2022

·

3 min read

Diabetic Ketoacidosis Market Size to Reach USD 1973.6 Million in 2027 | Industry Trend - Increasing Prevalence of Diabetes and Diabetic Ketoacidosis Across the Globe

According to Emergen Research, the global diabetic ketoacidosis market size was USD 1297.3 million in 2019 and is expected to reach USD 1973.6 million in 2027 and register a revenue CAGR of 6.2% during the forecast period, 2020-2027.

February 22, 2022

·

7 min read

Virtual Cardiology Market Report by Size, Share, Trend and Forecast to 2027

Virtual cardiology is a fast-emerging field of remote healthcare. Like many other telehealth branches, virtual cardiology pushed the boundaries of healthcare, evolving as a critical element of the digital transformation of cardiovascular care.

February 22, 2022

·

6 min read

Genetown

National Brain Tumor Society Launches DNA Damage Response Consortium with Yale

The National Brain Tumor Society announced the launch of its new flagship research initiative, the DNA Damage Response Consortium, in partnership with Yale Cancer Center.

February 22, 2022

·

4 min read

Business

Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022

Recro Pharma, Inc. announced that the company will release financial results for the fourth quarter and year-end 2021 after the market close on Tuesday, March 1, 2022.

February 22, 2022

·

2 min read

Business

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its financial results for the year ended December 31, 2021 and provide a corporate update after the close of U.S. financial markets on Tuesday, March 1, 2022.

February 22, 2022

·

1 min read

Pharm Country

Ocugen, Inc. Announces Proposed Public Offering of Common Stock - Feb 22, 2022

Ocugen, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, announced that it has commenced an underwritten public offering of its common stock.

February 22, 2022

·

3 min read

Biotech Bay

Amgen Issues Inaugural Green Bond To Advance ESG Goals

Amgen announced the issuance of its inaugural $750 million green bond, with a 3.000% semi-annual coupon and maturing in 2029, to advance the environmental goals that are part of Amgen’s environmental, social and governance framework.

February 22, 2022

·

9 min read